Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2019 Jan 21;78:88–100. doi: 10.1016/j.cct.2019.01.010

Table 1.

Study Eligibility Criteria

Inclusion Criteria
1. Willing and capable of giving written informed consent
2. Willing to comply with all study procedures and be available for the duration of the study
3. Males and females ages 18–39 years old at the start of the study (inclusive)
4. A minimum of two hypertension ICD-10 coded visits with a provider (MD, DO, PA, NP) on different dates in the last 24 months, with at least one code in the past 18 months
5. Medically homed at UW Health or Aurora Health Care
Exclusion Criteria
1. History of medically determined Congestive Heart Failure
2. Unable to provide informed consent (i.e., activated healthcare power of attorney)
3. Unable or unwilling to travel to local clinic for research visits
4. Currently residing in a skilled nursing facility
5. Diagnosed with sickle cell anemia or cystic fibrosis
6. Diagnosed with stroke, myocardial infarction, and/or coronary artery revascularization in the past 2 years
7. Syncope while exercising or doing strenuous activity within past 12 months
8. Currently prescribed warfarin, novel oral anticoagulant, or insulin
9. Planned organ transplant or prior transplant in the past 5 years
10. Chemotherapy or radiation therapy within 6 the past months
11. Severely impaired hearing, vision, or speech, as determined by study staff responsible for enrollment
12. Current participation or planning to participate in another clinical trial in the next 12 months
13. Pregnant or planning to become pregnant in the next 12 months
14. Planning to leave the geographic area in the next 6 months
15. Health condition that will limit both increasing physical activity and changing diet
16. Illegal drug use (other than marijuana) in the past 30 days
17. Unable to read or communicate in English
18. Currently on dialysis or seeing a Nephrologist
19. Between-arm blood pressure difference ≥20 mmHg
20. White Coat Hypertension (24-hour ambulatory monitoring)
21. Inability to comply with or complete the protocol or other reasons at the discretion of the principal and site investigators
22. Currently residing in correctional facility